Literature DB >> 4139171

Immunologic specificity of transfer factor.

K S Zuckerman, J A Neidhart, S P Balcerzak, A F LoBuglio.   

Abstract

This study examined the immunologic specificity of transfer factor using a chromatographically purified transfer factor preparation. The specificity of transfer was examined utilizing immunity to keyhole limpet hemocyanin (KLH) and tuberculin. Transfer factor prepared from a donor immune to KLH successfully transferred KLH skin test reactivity to 10 out of 10 recipients. In contrast, comparable amounts of transfer factor from two donors not immune to KLH failed to transfer immunity to KLH in 11 recipients despite evidence for successful transfer of tuberculin reactivity. Unlike prior studies with a variety of antigens, the immunity to KLH in recipients of KLH immune transfer factor appeared comparable to that of the donor since both could be elicited with the same skin test antigen dose. These observations indicate that transfer factor can initiate a specific immune response to an antigen not previously encountered by the recipient and that in certain circumstances this immune response can be comparable to that of the donor. These observations on specificity and potency of transfer factor have important implications for the clinical use of this material.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4139171      PMCID: PMC301641          DOI: 10.1172/JCI107841

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  13 in total

1.  Transfer of delayed hypersensitivity to coccidioidin in man.

Authors:  F T RAPAPORT; H S LAWRENCE; J W MILLAR; D PAPPAGIANIS; C E SMITH
Journal:  J Immunol       Date:  1960-04       Impact factor: 5.422

2.  Transfer of delayed hypersensitivity to skin homografts with leukocyte extracts in man.

Authors:  H S LAWRENCE; F T RAPAPORT; J M CONVERSE; W S TILLETT
Journal:  J Clin Invest       Date:  1960-01       Impact factor: 14.808

3.  Analogy of coccidioidin and histoplasmin sensitivity.

Authors:  C E SMITH
Journal:  Public Health Monogr       Date:  1956

4.  The transfer in humans of delayed skin sensitivity to streptococcal M substance and to tuberculin with disrupted leucocytes.

Authors:  H S LAWRENCE
Journal:  J Clin Invest       Date:  1955-02       Impact factor: 14.808

Review 5.  Transfer factor therapy in immune deficiency states.

Authors:  A S Levin; L E Spitler; H H Fudenberg
Journal:  Annu Rev Med       Date:  1973       Impact factor: 13.739

6.  The human primary immune response to keyhole limpet haemocyanin: interrelationships of delayed hypersensitivity, antibody response and in vitro blast transformation.

Authors:  J E Curtis; E M Hersh; J E Harris; C McBride; E J Freireich
Journal:  Clin Exp Immunol       Date:  1970-04       Impact factor: 4.330

Review 7.  Transfer factor.

Authors:  H S Lawrence
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

8.  Does transfer factor act specifically or as an immunologic adjuvant?

Authors:  B R Bloom
Journal:  N Engl J Med       Date:  1973-04-26       Impact factor: 91.245

9.  Transfer factor: isolation of a biologically active component.

Authors:  J A Neidhart; R S Schwartz; P E Hurtubise; S G Murphy; E N Metz; S P Balcerzak; A F LoBuglio
Journal:  Cell Immunol       Date:  1973-11       Impact factor: 4.868

10.  Antigen-specific immunity in recipients of leukocyte transfusions from immune donors.

Authors:  J E Curtis; E M Hersh; E J Freireich
Journal:  Cancer Res       Date:  1970-12       Impact factor: 12.701

View more
  6 in total

1.  Stimulation of monocyte cGMP by leukocyte dialysates. An antigen-independent property of dialyzable transfer factor.

Authors:  J A Sandler; T K Smith; V C Manganiello; C H Kirkpatrick
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

2.  Basophils in tuberculin and "Jones-Mote" delayed reactions of humans.

Authors:  P W Askenase; J E Atwood
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

3.  Transfer factor: failure to transfer reactivity in normal human subjects.

Authors:  L E Spitler
Journal:  Clin Exp Immunol       Date:  1980-03       Impact factor: 4.330

4.  [Transfer factor (TF) treatment of patients with HBs-Ag-positive chronic active hepatitis. A prospective, controlled study (author's transl)].

Authors:  C P Sodomann; G Maerker-Alzer; K Havemann; C Dienst; H Schultz; D Mitrenga; K Schumacher; G A Martini
Journal:  Klin Wochenschr       Date:  1979-09-03

5.  Guinea pig transfer factor-like activity detected in vitro.

Authors:  W Dunnick; F H Bach
Journal:  Proc Natl Acad Sci U S A       Date:  1975-11       Impact factor: 11.205

6.  Transfer factor.

Authors:  A S Hamblin
Journal:  J R Soc Med       Date:  1979-12       Impact factor: 18.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.